Request Demo
Last update 09 Dec 2025
Emicizumab biosimilar (Chia Tai Tianqing)
Last update 09 Dec 2025
Overview
Basic Info
Drug Type Bispecific antibody, Biosimilar |
Synonyms Emicizumab Biosimilar (Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.), 艾美赛珠单抗生物类似药（南京正大天晴制药有限公司）, NTB001 |
Target |
Action inhibitors |
Mechanism F10 inhibitors(Coagulation factor X inhibitors), factor IXa inhibitors(Factor IXa inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 5386H
The sequence is quoted from: *****
Sequence Code 5425H
The sequence is quoted from: *****
Sequence Code 5467L
The sequence is quoted from: *****
Related
1
Clinical Trials associated with Emicizumab biosimilar (Chia Tai Tianqing)CTR20254539
在中国健康男性受试者中比较NTB001注射液与舒友立乐®（艾美赛珠单抗注射液）的药代动力学特征、安全性和免疫原性的随机、双盲、平行对照的I期临床研究
[Translation] A randomized, double-blind, parallel-controlled phase I clinical trial comparing the pharmacokinetic characteristics, safety, and immunogenicity of NTB001 injection with Shuyoulile® (Emicyzilumab injection) in healthy male subjects in China.
100 Clinical Results associated with Emicizumab biosimilar (Chia Tai Tianqing)
Login to view more data
100 Translational Medicine associated with Emicizumab biosimilar (Chia Tai Tianqing)
Login to view more data
100 Patents (Medical) associated with Emicizumab biosimilar (Chia Tai Tianqing)
Login to view more data
100 Deals associated with Emicizumab biosimilar (Chia Tai Tianqing)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hemophilia A | Phase 1 | China | 17 Nov 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free